Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting,
https://www.reuters.com/business/healthcare-pharmaceuticals/low-start-dose-amgen-experimental-weight-loss-drug-limits-side-effects-2025-06-23/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.